Literature DB >> 21559778

Ezrin mRNA target site selection for DNAzymes using secondary structure and hybridization thermodynamics.

YaoFei Wang1, JingNan Shen, XiFu Shang, Jin Wang, JingChun Li, JunQiang Yin, ChangYe Zou.   

Abstract

Ezrin, a membrane organizer and linker between plasma membrane and cytoskeleton, is well documented to play an important role in the metastatic capacity of cancer cells especially for osteosarcoma cells. It has provided an ideal target for cancer gene therapy. RNA-cleaving 10-23 DNAzymes, consisting of a 15-nucleotide catalytical domain flanked by two target-specific complementary arms, can cleave the target mRNA at purine-pyrimidine dinucleotide effectively. In the present study, we designed and screened the target sites for 10-23 DNAzymes against ezrin mRNA by using multiple computational methods with combination of secondary structural and hybridization thermodynamic parameters. Then, we testified the activities of the DNAzymes directed against these selected target sites in vitro. Our results show that AU1751 is the most effective target site of ezrin mRNA for DNAzymes because of its ideal secondary structure and hybridization thermodynamics. So, there is a significant correlation between the multiple computational methods and the efficacy of the corresponding DNAzymes. These provide a rational, efficient way for DNAzymes selection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21559778     DOI: 10.1007/s13277-011-0183-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  64 in total

1.  Predicting oligonucleotide affinity to nucleic acid targets.

Authors:  D H Mathews; M E Burkard; S M Freier; J R Wyatt; D H Turner
Journal:  RNA       Date:  1999-11       Impact factor: 4.942

2.  Keeping the biotechnology of antisense in context.

Authors:  C A Stein
Journal:  Nat Biotechnol       Date:  1999-03       Impact factor: 54.908

3.  Target site selection for an RNA-cleaving catalytic DNA.

Authors:  M J Cairns; T M Hopkins; C Witherington; L Wang; L Q Sun
Journal:  Nat Biotechnol       Date:  1999-05       Impact factor: 54.908

4.  A rapid in vitro method for obtaining RNA accessibility patterns for complementary DNA probes: correlation with an intracellular pattern and known RNA structures.

Authors:  O Matveeva; B Felden; S Audlin; R F Gesteland; J F Atkins
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

5.  Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor.

Authors:  Torgeir Holen; Mohammed Amarzguioui; Merete T Wiiger; Eshrat Babaie; Hans Prydz
Journal:  Nucleic Acids Res       Date:  2002-04-15       Impact factor: 16.971

6.  Optimisation of the 10-23 DNAzyme-substrate pairing interactions enhanced RNA cleavage activity at purine-cytosine target sites.

Authors:  Murray J Cairns; Andrew King; Lun-Quan Sun
Journal:  Nucleic Acids Res       Date:  2003-06-01       Impact factor: 16.971

7.  Gene silencing nucleic acids designed by scanning arrays: anti-EGFR activity of siRNA, ribozyme and DNA enzymes targeting a single hybridization-accessible region using the same delivery system.

Authors:  Gary Beale; Andrew J Hollins; Mustapha Benboubetra; Muhammad Sohail; Stephen P Fox; Ibrahim Benter; Saghir Akhtar
Journal:  J Drug Target       Date:  2003-08       Impact factor: 5.121

8.  Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer Data Base Report.

Authors:  Timothy A Damron; William G Ward; Andrew Stewart
Journal:  Clin Orthop Relat Res       Date:  2007-06       Impact factor: 4.176

9.  Design of efficient DNAzymes against muscle AChR alpha-subunit cRNA in vitro and in HEK 293 cells.

Authors:  Amr Abdelgany; M Khabir Uddin; Matthew Wood; Kazunari Taira; David Beeson
Journal:  J RNAi Gene Silencing       Date:  2005-10-14

10.  A structural analysis of in vitro catalytic activities of hammerhead ribozymes.

Authors:  Yu Shao; Susan Wu; Chi Yu Chan; Jessie R Klapper; Erasmus Schneider; Ye Ding
Journal:  BMC Bioinformatics       Date:  2007-11-30       Impact factor: 3.169

View more
  2 in total

1.  Inhibition of HIV-1 Integrase gene expression by 10-23 DNAzyme.

Authors:  Nirpendra Singh; Atul Ranjan; Souvik Sur; Ramesh Chandra; Vibha Tandon
Journal:  J Biosci       Date:  2012-07       Impact factor: 1.826

2.  The clinical significance of changes in ezrin expression in osteosarcoma of children and young adults.

Authors:  Iwona Lugowska; Ewa Mierzejewska; Malgorzata Lenarcik; Teresa Klepacka; Irena Koch; Elzbieta Michalak; Katarzyna Szamotulska
Journal:  Tumour Biol       Date:  2016-05-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.